
Posted: 9/1/2010
|
The porcine circovirus contamination of GSK’s Rotarix vaccine in March of this year, and previous contaminations in both Baxter and Genzyme biological products in 2009, have highlighted the issue of viral safety in biologics more than ever before. In a recent interview Dr. Mark Plavsic, Senior Director, Gene Therapy Development Genzyme, spoke with Andrea Charles from Pharma IQ,...
Full Article |
- Assessing the Impact of Single-Use Biomanufacturing Systems 9/3/2010
- Boosting Bioavailability Through Partnerships 9/3/2010
- Integration and Interoperability in the Laboratory: Will You Find Your Match? 9/2/2010
- Will SDMS Become ELN of the Future? 9/2/2010
- Biopharmaceutical Cold Chain: Investing in the MENA Region 9/1/2010
- Improving Hospital Efficiency Through Technology 9/1/2010
Boosting Bioavailability Through Partnerships
Contributor: Pharma IQPosted: 9/3/2010
|
If the trends that have been seen in the pharmaceutical industry over the past few years prove anything, it is that drug development companies are increasingly recognising the value of teamwork. There is plenty of evidence that businesses in the sector are seeing the benefits that partners...
Full Article |
The Human Factor’s Engineering Process in the Development of Medical Device Software
Contributor: Edmond IsraelskiPosted: 8/27/2010
View this presentation to find out about integrating human factors engineering into medical devices to make them safe, effective and efficient to use, and the regulations for the human factors engineering process. Presented by Dr. Edmond W. Israelski, Hum... Full Article |
Assessing the Impact of Single-Use Biomanufacturing Systems
Contributor: Pharma IQPosted: 9/3/2010
Whilst single-use systems have brought many advantages for bioprocessing, such as accelerated downtime and reduced costs, there are still some challenges that need to be addressed. Dr. Kit Erlebach, Head of Technical Commercial Manufacturing at Avecia, and Tony Hitchcoc... Full Article |
The Dynamic Market: The Most Important Market Segment for Your Brand
Posted: 9/3/2010The following interviews are part of a Five-Part Series on Marketing Excellence, which draws on landmark IMS research on more than 3,000 new product launches and analysis of 50 in-line brands spanning 10 chronic retail markets. Each offers insights from an IMS expert on best practices... Full Article |
-
BioPatent Design
September 7-9, 2010,
Hilton Munich Park, Munich, Germany -
Pharmaceutical Distribution 2010
September 8-9, 2010,
Mövenpick Hotel, Amsterdam, The Netherlands -
PAT Implementation Strategies for Pharmaceuticals & Biotech
September 13-15, 2010,
Philadelphia, PA
|
|
What documents are required for ANDA submission and how does the process work? Are the any good online guides? |
Posted by: Sumit Dutta | Answer this question
|
|
hi i was asking do i need a wrirten permision from you to write about your site or the news in your sit but i guide people to your site to register in the... |
Posted by: eman desouky | Answer this question
|
|
Is there a group on this site for people involved with SNP/Genetic research? |
Posted by: almour | Answer this question
|
|
What documents are required for ANDA submission and how does the process work? |
Posted By: Sumit Dutta | Answer this question




















